Synergistic effect of released aspirin/heparin for preventing bovine pericardial calcification

Artificial Organs

Volumn 24, Issue 2, 2000, Pages 129-136

  Vasudev, Sindhu C ^a   Chandy, Thomas ^a   Sharma, Chandra P ^a   Mohanty, Mira ^a   Umasankar, P R ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Alkaline phosphatase; Aspirin heparin release; Bovine pericardium; Calcification

Indexed keywords

ALKALINITY; BIOMINERALIZATION; CONTROLLED DRUG DELIVERY; MAMMALS; PHOSPHATASES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYSACCHARIDES; TARGETED DRUG DELIVERY;

ALKALINE PHOSPHATASE; ASPIRIN/HEPARIN RELEASE; BIOPROSTHETIC HEART VALVES; BOVINE PERICARDIUM; CLINICAL FAILURE; CO-MATRIX; GLUTARALDEHYDES; IN-VITRO; SYNERGISTIC EFFECT; VITRO AND IN VIVO;

BONE;

ACETYLSALICYLIC ACID; HEPARIN;

ANIMAL TISSUE; ARTICLE; CALCIFICATION; CATTLE; DRUG EFFECT; DRUG POTENTIATION; NONHUMAN; PERICARDIAL DISEASE; PRIORITY JOURNAL;

ANIMALIA; BOS TAURUS; BOVINAE;

EID: 0034083435     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2000.06348.x     Document Type: Article

References (32)

1. 1. Schoen FJ, Levy RJ. Bioprosthetic heart valve failure pathology and pathogenesis. Cardiol Clin 1984;2:217-23.
2. 2. Schoen FJ, Levy RJ, Nelson AC. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest 1985;52:523-6.
3. 3. Levy RJ, Schoen FJ, Levy JT. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983;113:143-55.
4. 4. Schoen FJ, Levy RJ. Pathophysiology of bioprosthetic heart valve calcification. In: Bodnar E, Yacoub MH, eds. Biological and Bioprosthetic valves. New York: Yorke, 1986:418.
5. 5. Ferrans VJ, Boyce SW, Billingham ME. Calcific deposits in porcine bioprosthesis, structure, and pathogenesis. Am J Cardiol 1980;46:721-34.
6. 6. Nosé Y, Harasaki J, Murray J. Mineralization of artificial surfaces that contact blood. Trans Am Soc Artif Intern Organs 1981;27:714-20.
7. 7. Anderson HC. Normal and abnormal mineralization in mammals. Trans Am Soc Artif Intern Organs 1981;27:702-8.
8. 8. Kim KM. Role of membranes in calcification. Surv Synth Pathol Res 1983;2:215-28.
9. 9. Socben JF, Harasaki H, Kim KM, Anderson HG, Levy RJ. Biomaterials associated calcification. Pathology, mechanism, and strategies for prevention. J Biomed Mater Res 1988;22: 11-36.
10. 3 preincubations. J Biomed Mater Res 1991;25:905-35.
11. 3+, protamine sulfate, and levamisole. Biomaterials 1990;11:718-23.
12. 12. Levy RJ, Jonston TP, Sintor A, Golomb G. Controlled release implants for cardiovascular disease. J Contr Rel 1990;11: 245-54.
13. 13. Chandy T, Ajith Kumar B, Sharma CP. Inhibition of in vitro calcium phosphate precipitation in the presence of polyurethane via surface modification and drug delivery. J Appl Biomaterials 1994;5:245-54.
14. 14. Chandy T, Mohanty M, John A, Rao SB, Sivakumar R, Sharma CP, Valiathan MS. Structural studies on bovine bioprosthetic tissues and their in vivo calcification prevention via drug delivery. Biomaterials 1996;17(6):577-85.
15. 15. Haak JC. Mechanism of action. Aspirin Thromb Res Suppl 1983;IV:47-57.
16. 16. Plate NA, Valuev L. One of the mechanisms of enhanced thromboresistance of polymeric materials in the presence of heparin. Biomaterials 1983;939:14-20.
17. 17. Vasudev SC, Chandy T, Sharma CP. Development of chitosan/polyethylene vinyl acetate co-matrix controlled release of aspirin-heparin for preventing thrombosis. Biomaterials 1997;18:375-81.
18. 18. Vasudev SC, Chandy T. Effect of alternative crosslinking techniques on the enzymatic degradation of bovine pericardium and their calcification. J Biomed Mater Res 1997;35: 357-69.
19. 19. Pasquino E, Pascale S, Anderson M, Rinaldi S, Laborde F, Galloni M. Bovine pericardium for heart valve bioprostheses in vitro and in vivo characterization of new chemical treatments. J Mater Sci Mater Med 1992;3:272.
20. 20. Courtman DW, Pereira CA, Kashef V, McComb D, Lee JM, Wilson GJ. Development of a pericardial acellular matrix biomaterial. Biochemical and mechanical effects of cell extraction. J Biomed Mater Res 1994;28:655-66.
21. 21. Smith PK, Mallia AK, Hermanson GT. Colorimetric method for the assay of heparin content in immobilized heparin preparations. Analyt Biochem 1980;109:455-73.
22. 22. Golomb G, Wagner D. Development of a new in vitro model for studying implantable polyurethane calcification. Biomaterials 1991;12:397-405.
23. 23. Varley H. Practical biochemistry. New York: William Heinemann Medical Books Ltd. and Interscience Books INC. 1967:480-3.
24. 24. Vasudev SC, Chandy T, Sharma CP. The antithrombotic versus calcium antagonistic effects of polyethylene glycol grafted bovine pericardium. J Bimat Appl 1999;14:48-56.
25. 25. Chandy T, Vasudev SC, Sharma CP. Changes in polyurethane calcification due to antibiotics. Artif Organs 1996;20(7): 752-60.
26. 26. Chandy T, Sharma CP. Anesthetic and ferric-magnesium ion combination as calcium antagonists for glutaraldehyde treated pericardial tissues. Clin Materials 1994;17:165-72.
27. 27. Weiss HJ, Aledort LM, Kochwa S. The effect of salicylates on the haemostatic properties of platelets in man. J Clin Invest 1968;47:2169-72.
28. 28. Vroman L, Adams AL, Fisher GC, Munoz PC, Stanford M. Proteins, plasma, and blood in narrow spaces of clot promoting surfaces. Adv Chem 1982;199:266-76.
29. 29. Vyavahare NR, Fuller A, Levy RJ. Controlled release of heparin from polymers. Effect on calcification of porcine aortic cusps. Proceedings of the 5th World Biomaterials Congress, Toronto, Canada 1996;II:733.
30. 30. Han DK, Jeong SV, Kim YH. Evaluation of blood compatibility of PEO grafted and heparin immobilized polyurethane. J Biomed Mater Res Appl Biomat 1989;23:211-28.
31. 31. Merril EW, Salzman EW. Polyethylene oxide as a biomaterial. J Am Artif Intern Organs 1983;6(2):60-4.
32. 32. Levy RJ, Schoen FJ, Golomb G. Bioprosthetic heart valve calcification: Clinical features, pathobiology, and prospects for prevention. CRC Crit Rev Biocompat 1986;2:147-87.